Factors Associated With Treatment Uptake Among People Tested for HCV RNA in Prison and Community in the NSW DBS Study, September 2017–December 2020 (n = 863)
| Variables . | Detectable HCV RNA, No. . | Initiated Treatment Within 6 Months . | Unadjusted Odds Ratio (95% CI) . | Adjusted Odds Ratio (95% CI) . | |
|---|---|---|---|---|---|
| No. . | % . | ||||
| Overall | 863 | 384 | 44 | … | … |
| Registration type | |||||
| Assisted (community) | 409 | 107 | 26 | 1 | 1 |
| Assisted (prison) | 454 | 277 | 61 | 4.42 (3.30–5.90) | 4.28 (3.04–6.03) |
| Gender | |||||
| Men | 652 | 316 | 48 | 1 | 1 |
| Women | 199 | 64 | 32 | 0.50 (0.36–0.70) | 0.68 (0.47–0.97) |
| Other | 12 | 4 | 33 | 0.53 (0.16–1.78) | 0.92 (0.27–3.19) |
| Age | |||||
| ≤25 y | 110 | 68 | 62 | 1 | 1 |
| 25–34 y | 211 | 106 | 50 | 0.62 (0.39–1.00) | 0.67 (0.41–1.09) |
| 35–44 y | 277 | 114 | 41 | 0.43 (0.27–0.68) | 0.78 (0.48–1.27) |
| 45–54 y | 215 | 86 | 40 | 0.41 (0.26–0.66) | 1.02 (0.60–1.74) |
| >55 y | 50 | 10 | 20 | 0.15 (0.07–0.34) | 0.43 (0.18–1.01) |
| Aboriginal and/or Torres Strait Islander | |||||
| No | 519 | 220 | 42 | 1 | … |
| Yes | 344 | 164 | 48 | 1.24 (0.94–1.63) | … |
| Born outside of Australia | |||||
| No | 798 | 356 | 45 | 1 | … |
| Yes, Asia or Africa | 16 | 7 | 44 | 0.97 (0.36–2.62) | … |
| Yes, other | 49 | 21 | 43 | 0.93 (0.52–1.67) | … |
| Speaks English at home | |||||
| No | 34 | 18 | 53 | 1 | … |
| Yes | 829 | 366 | 44 | 0.70 (0.35–1.40) | … |
| Recently injected drugs | |||||
| No | 185 | 84 | 45 | 1 | … |
| Yes | 662 | 288 | 44 | 0.93 (0.67–1.28) | … |
| Prefer not to say | 16 | 12 | 75 | 3.61 (1.12–11.60) | … |
| Variables . | Detectable HCV RNA, No. . | Initiated Treatment Within 6 Months . | Unadjusted Odds Ratio (95% CI) . | Adjusted Odds Ratio (95% CI) . | |
|---|---|---|---|---|---|
| No. . | % . | ||||
| Overall | 863 | 384 | 44 | … | … |
| Registration type | |||||
| Assisted (community) | 409 | 107 | 26 | 1 | 1 |
| Assisted (prison) | 454 | 277 | 61 | 4.42 (3.30–5.90) | 4.28 (3.04–6.03) |
| Gender | |||||
| Men | 652 | 316 | 48 | 1 | 1 |
| Women | 199 | 64 | 32 | 0.50 (0.36–0.70) | 0.68 (0.47–0.97) |
| Other | 12 | 4 | 33 | 0.53 (0.16–1.78) | 0.92 (0.27–3.19) |
| Age | |||||
| ≤25 y | 110 | 68 | 62 | 1 | 1 |
| 25–34 y | 211 | 106 | 50 | 0.62 (0.39–1.00) | 0.67 (0.41–1.09) |
| 35–44 y | 277 | 114 | 41 | 0.43 (0.27–0.68) | 0.78 (0.48–1.27) |
| 45–54 y | 215 | 86 | 40 | 0.41 (0.26–0.66) | 1.02 (0.60–1.74) |
| >55 y | 50 | 10 | 20 | 0.15 (0.07–0.34) | 0.43 (0.18–1.01) |
| Aboriginal and/or Torres Strait Islander | |||||
| No | 519 | 220 | 42 | 1 | … |
| Yes | 344 | 164 | 48 | 1.24 (0.94–1.63) | … |
| Born outside of Australia | |||||
| No | 798 | 356 | 45 | 1 | … |
| Yes, Asia or Africa | 16 | 7 | 44 | 0.97 (0.36–2.62) | … |
| Yes, other | 49 | 21 | 43 | 0.93 (0.52–1.67) | … |
| Speaks English at home | |||||
| No | 34 | 18 | 53 | 1 | … |
| Yes | 829 | 366 | 44 | 0.70 (0.35–1.40) | … |
| Recently injected drugs | |||||
| No | 185 | 84 | 45 | 1 | … |
| Yes | 662 | 288 | 44 | 0.93 (0.67–1.28) | … |
| Prefer not to say | 16 | 12 | 75 | 3.61 (1.12–11.60) | … |
Abbreviation: HCV, hepatitis C virus.
Factors Associated With Treatment Uptake Among People Tested for HCV RNA in Prison and Community in the NSW DBS Study, September 2017–December 2020 (n = 863)
| Variables . | Detectable HCV RNA, No. . | Initiated Treatment Within 6 Months . | Unadjusted Odds Ratio (95% CI) . | Adjusted Odds Ratio (95% CI) . | |
|---|---|---|---|---|---|
| No. . | % . | ||||
| Overall | 863 | 384 | 44 | … | … |
| Registration type | |||||
| Assisted (community) | 409 | 107 | 26 | 1 | 1 |
| Assisted (prison) | 454 | 277 | 61 | 4.42 (3.30–5.90) | 4.28 (3.04–6.03) |
| Gender | |||||
| Men | 652 | 316 | 48 | 1 | 1 |
| Women | 199 | 64 | 32 | 0.50 (0.36–0.70) | 0.68 (0.47–0.97) |
| Other | 12 | 4 | 33 | 0.53 (0.16–1.78) | 0.92 (0.27–3.19) |
| Age | |||||
| ≤25 y | 110 | 68 | 62 | 1 | 1 |
| 25–34 y | 211 | 106 | 50 | 0.62 (0.39–1.00) | 0.67 (0.41–1.09) |
| 35–44 y | 277 | 114 | 41 | 0.43 (0.27–0.68) | 0.78 (0.48–1.27) |
| 45–54 y | 215 | 86 | 40 | 0.41 (0.26–0.66) | 1.02 (0.60–1.74) |
| >55 y | 50 | 10 | 20 | 0.15 (0.07–0.34) | 0.43 (0.18–1.01) |
| Aboriginal and/or Torres Strait Islander | |||||
| No | 519 | 220 | 42 | 1 | … |
| Yes | 344 | 164 | 48 | 1.24 (0.94–1.63) | … |
| Born outside of Australia | |||||
| No | 798 | 356 | 45 | 1 | … |
| Yes, Asia or Africa | 16 | 7 | 44 | 0.97 (0.36–2.62) | … |
| Yes, other | 49 | 21 | 43 | 0.93 (0.52–1.67) | … |
| Speaks English at home | |||||
| No | 34 | 18 | 53 | 1 | … |
| Yes | 829 | 366 | 44 | 0.70 (0.35–1.40) | … |
| Recently injected drugs | |||||
| No | 185 | 84 | 45 | 1 | … |
| Yes | 662 | 288 | 44 | 0.93 (0.67–1.28) | … |
| Prefer not to say | 16 | 12 | 75 | 3.61 (1.12–11.60) | … |
| Variables . | Detectable HCV RNA, No. . | Initiated Treatment Within 6 Months . | Unadjusted Odds Ratio (95% CI) . | Adjusted Odds Ratio (95% CI) . | |
|---|---|---|---|---|---|
| No. . | % . | ||||
| Overall | 863 | 384 | 44 | … | … |
| Registration type | |||||
| Assisted (community) | 409 | 107 | 26 | 1 | 1 |
| Assisted (prison) | 454 | 277 | 61 | 4.42 (3.30–5.90) | 4.28 (3.04–6.03) |
| Gender | |||||
| Men | 652 | 316 | 48 | 1 | 1 |
| Women | 199 | 64 | 32 | 0.50 (0.36–0.70) | 0.68 (0.47–0.97) |
| Other | 12 | 4 | 33 | 0.53 (0.16–1.78) | 0.92 (0.27–3.19) |
| Age | |||||
| ≤25 y | 110 | 68 | 62 | 1 | 1 |
| 25–34 y | 211 | 106 | 50 | 0.62 (0.39–1.00) | 0.67 (0.41–1.09) |
| 35–44 y | 277 | 114 | 41 | 0.43 (0.27–0.68) | 0.78 (0.48–1.27) |
| 45–54 y | 215 | 86 | 40 | 0.41 (0.26–0.66) | 1.02 (0.60–1.74) |
| >55 y | 50 | 10 | 20 | 0.15 (0.07–0.34) | 0.43 (0.18–1.01) |
| Aboriginal and/or Torres Strait Islander | |||||
| No | 519 | 220 | 42 | 1 | … |
| Yes | 344 | 164 | 48 | 1.24 (0.94–1.63) | … |
| Born outside of Australia | |||||
| No | 798 | 356 | 45 | 1 | … |
| Yes, Asia or Africa | 16 | 7 | 44 | 0.97 (0.36–2.62) | … |
| Yes, other | 49 | 21 | 43 | 0.93 (0.52–1.67) | … |
| Speaks English at home | |||||
| No | 34 | 18 | 53 | 1 | … |
| Yes | 829 | 366 | 44 | 0.70 (0.35–1.40) | … |
| Recently injected drugs | |||||
| No | 185 | 84 | 45 | 1 | … |
| Yes | 662 | 288 | 44 | 0.93 (0.67–1.28) | … |
| Prefer not to say | 16 | 12 | 75 | 3.61 (1.12–11.60) | … |
Abbreviation: HCV, hepatitis C virus.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
